India | July 20, 2025 — Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leader in research-led pharmaceutical innovation, has been awarded the prestigious World Health Organization (WHO) Good Distribution Practices (GDP) Certification for its Supply Chain Unit-II in Baddi, Himachal Pradesh. The certification, granted by Société Générale de Surveillance (SGS), affirms Venus Remedies’ global standards in distribution and supply chain excellence.
Global Recognition for Compliance & Delivery The endorsement follows a rigorous audit that validated Venus Remedies’ compliance with international pharma logistics protocols—from manufacturing through to last-mile delivery.
“The WHO GDP certification reinforces our commitment to delivering safe and effective medicines with precision and transparency,” said Mr. Saransh Chaudhary, President, Global Critical Care & CEO, Venus Medicine Research Centre.
Digital-First, IoT-Enabled Logistics Model Venus Remedies has implemented a comprehensive digital supply chain system, utilizing IoT tools to monitor shipment conditions like temperature, humidity, and geolocation in real time. Proprietary warehousing algorithms have further streamlined cartonization and shipping—resulting in 50% faster delivery times and reduced operational costs.
Direct-to-Pharmacy Logistics Expansion The company now operates a parallel online delivery network, equipped with real-time tracking, digital payment processing, and live customer support. This expansion strengthens its reach across pharmacies and small retailers nationwide.
“Embedding quality across every layer of our operations is key to our vision,” stated Mr. Peeyush Jain, Deputy Managing Director, Venus Remedies. “The WHO GDP certification is a validation of our logistics innovation and strategic pursuit of global trust in healthcare.”
Robust Compliance Footprint Venus Remedies holds 25+ GMP certifications, including the latest approval from Ukraine, bolstering its manufacturing credibility on a global scale. Together with WHO GDP, these credentials emphasize the company’s commitment to safety, integrity, and pharmaceutical excellence across the value chain.
